瘢痕疙瘩相关淋巴组织中胚胎干细胞样细胞表达肾素-血管紧张素系统组分
该研究通过免疫组化、免疫荧光、实时定量PCR和蛋白质印迹法,检测了11例瘢痕疙瘩组织中肾素原受体、血管紧张素转换酶、血管紧张素II受体1和2的表达。结果显示这些蛋白在瘢痕疙瘩相关淋巴组织内的胚胎干细胞样细胞群中表达,提示该原始细胞群可能通过调节肾素-血管紧张素系统成为潜在治疗靶点。
要点
- 肾素原受体和AT1受体表达于微血管内皮和周细胞层及血管周细胞。
- AT2受体定位于微血管内皮和类胰蛋白酶阳性血管周细胞。
- ACE定位于瘢痕疙瘩相关淋巴组织内微血管内皮。
核心结论
- 肾素原受体、ACE、AT1受体和AT2受体由瘢痕疙瘩相关淋巴组织内的胚胎干细胞样细胞群表达,提示该原始细胞群可能通过调节肾素-血管紧张素系统成为潜在治疗靶点。
研究设计与样本
- 对11例福尔马林固定石蜡包埋的瘢痕疙瘩组织切片进行免疫组化染色。
- 对3例瘢痕疙瘩组织进行免疫荧光共染色(OCT4、CD34、ERG、类胰蛋白酶)。
- 对5例瘢痕疙瘩组织和4株瘢痕疙瘩原代细胞系进行实时定量PCR。
- 对4株瘢痕疙瘩原代细胞系进行蛋白质印迹法检测mRNA和蛋白表达。
主要发现
- 免疫组化和免疫荧光显示所有11例瘢痕疙瘩组织样本均表达肾素原受体、ACE、AT1受体和AT2受体。
- 肾素原受体和AT1受体表达于微血管内皮和周细胞层及血管周细胞。
- AT2受体定位于微血管内皮和类胰蛋白酶阳性血管周细胞。
- ACE定位于瘢痕疙瘩相关淋巴组织内微血管内皮。
- 实时定量PCR显示肾素原受体、ACE和AT1受体转录本在瘢痕疙瘩组织和原代细胞系中均检出,而AT2受体仅在瘢痕疙瘩组织中检出;蛋白质印迹法证实原代细胞系中存在肾素原受体、ACE和AT1受体。
临床怎么用
- 提示肾素-血管紧张素系统组分可能作为瘢痕疙瘩治疗的潜在靶点,但尚需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated expression of prorenin receptor, angiotensin-converting enzyme, angiotensin II receptor 1, and angiotensin II receptor 2 by the embryonic stem cell-like population on the endothelium of the microvessels and perivascular cells within keloid-associated lymphoid tissues. METHODS: Immunohistochemical staining for prorenin receptor, angiotensin-converting enzyme, angiotensin II receptor 1, and angiotensin II receptor 2 was performed on 11 formalin-fixed, paraffin-embedded sections of keloid tissue samples. Immunofluorescence staining was performed on three keloid tissue samples by co-staining with OCT4, CD34, ERG, and tryptase. Real-time quantitative polymerase chain reaction was performed on five keloid tissue samples and four keloid-derived primary cell lines. Western blotting was performed on the four keloid-derived primary cell lines for mRNA and protein expression of these proteins, respectively. RESULTS: Immunohistochemical and immunofluorescence staining showed expression of prorenin receptor, angiotensin-converting enzyme, angiotensin II receptor 1, and angiotensin II receptor 2 in all 11 keloid tissue samples. Prorenin receptor and angiotensin II receptor 1 were expressed on the endothelium and the pericyte layer of the microvessels and perivascular cells, angiotensin II receptor 2 was localized to the endothelium of the microvessels and the tryptase-positive perivascular cells, and angiotensin-converting enzyme was localized to the endothelium of the microvessel, within the keloid-associated lymphoid tissues. Real-time quantitative polymerase chain reaction showed transcripts of prorenin receptor, angiotensin-converting enzyme, and angiotensin II receptor 1 in the keloid tissue samples and keloid-derived primary cell lines, whereas angiotensin II receptor 2 was detected in keloid tissue samples only. Western blotting confirmed the presence of prorenin receptor, angiotensin-converting enzyme, and angiotensin II receptor 1 in the keloid-derived primary cell lines. CONCLUSION: Prorenin receptor, angiotensin-converting enzyme, angiotensin II receptor 1, and angiotensin II receptor 2 were expressed by the embryonic stem cell-like population within the keloid-associated lymphoid tissues, suggesting that this primitive population may be a potential therapeutic target by modulation of the renin-angiotensin system.
引用
- Humphries H, Brasch HD, van Schaijik B, et al. Expression of Components of the Renin-Angiotensin System by the Embryonic Stem Cell-Like Population within Keloid Lesions. Plast Reconstr Surg. 2019. PMID: 31348346. doi:10.1097/PRS.0000000000005867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。